NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace dying cells in retina
National Institutes of Health (NIH) sent this bulletin at 12/16/2019 12:30 PM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
12/16/2019 11:45 AM EST
NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.
Update Your E-mail Address | Add Subscriptions | Unsubscribe
If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view our Frequently Asked Questions page, our Health Information page, or Search our website.
This service is provided to you by the National Institutes of Health.
NIH…Turning Discovery Into Health®
 |